NEW YORK (GenomeWeb News) – Investigators at the
Rutgers Cancer Institute of New Jersey (CINJ) and the University of Wisconsin Carbone Cancer Center have won a $4.3 million grant from the National Cancer Institute to conduct a clinical trial seeking to identify and use genomic biomarkers to provide targeted cancer treatments, CINJ said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.